NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
09 2023
Historique:
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.

Identifiants

pubmed: 37673117
doi: 10.6004/jnccn.2023.0046
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

900-909

Auteurs

Therese B Bevers (TB)

The University of Texas MD Anderson Cancer Center.

Bethany L Niell (BL)

Moffitt Cancer Center.

Jennifer L Baker (JL)

UCLA Jonsson Comprehensive Cancer Center.

Debbie L Bennett (DL)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Ermelinda Bonaccio (E)

Roswell Park Comprehensive Cancer Center.

Melissa S Camp (MS)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Sona Chikarmane (S)

Dana-Farber/Brigham and Women's Cancer Center.

Emily F Conant (EF)

Abramson Cancer Center at the University of Pennsylvania.

Mohammad Eghtedari (M)

UC San Diego Moores Cancer Center.

Meghan R Flanagan (MR)

Fred Hutchinson Cancer Center.

Jeffrey Hawley (J)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Mark Helvie (M)

University of Michigan Rogel Cancer Center.

Linda Hodgkiss (L)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Tamarya L Hoyt (TL)

Vanderbilt-Ingram Cancer Center.

Jennifer Ivanovich (J)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Maxine S Jochelson (MS)

Memorial Sloan Kettering Cancer Center.

Swati Kulkarni (S)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Rachael B Lancaster (RB)

O'Neal Comprehensive Cancer Center at UAB.

Caitlin Mauer (C)

UT Southwestern Simmons Comprehensive Cancer Center.

Jessica Maxwell (J)

Fred & Pamela Buffett Cancer Center.

Bhavika K Patel (BK)

Mayo Clinic Comprehensive Cancer Center.

Mark Pearlman (M)

University of Michigan Rogel Cancer Center.

Liane Philpotts (L)

Yale Cancer Center/Smilow Cancer Hospital.

Donna Plecha (D)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Jennifer K Plichta (JK)

Duke Cancer Institute.

Shadi Shakeri (S)

UC Davis Comprehensive Cancer Center.

Mary Lou Smith (ML)

Research Advocacy Network.

Clarie L Streibert (CL)

Fox Chase Cancer Center.

Roberta M Strigel (RM)

University of Wisconsin Carbone Cancer Center.

Lusine Tumyan (L)

City of Hope National Medical Center.

Nicole S Winkler (NS)

Huntsman Cancer Institute at the University of Utah.

Dulcy E Wolverton (DE)

University of Colorado Cancer Center.

Mary Anne Bergman (MA)

National Comprehensive Cancer Network.

Rashmi Kumar (R)

National Comprehensive Cancer Network.

Katie Stehman (K)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH